| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| DONNA D. WADE, CPA-TAX FEES | 30,000 | 30,000 | 0 | |
| LESS: FEES ALLOC TO 990-T | 0 | -6,000 | 0 |
| Category | Amount |
|---|---|
| NONE | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AUTOZONE, INC. STOCK | 6,144 | 840,323 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| 1607 CAPITAL PARTNERS BD FUND, LP | AT COST | 637,244 | 561,484 |
| FIRST EAGLE GLOBAL FUND | AT COST | 898,887 | 1,124,016 |
| GT BIOTECH FUND, LP | AT COST | 839,771 | 859,033 |
| GT CREDIT OPPORTUNITY FUND, LP | AT COST | 23,567 | 22,204 |
| GT EMERGING MARKETS, LP | AT COST | 1,970,771 | 1,926,328 |
| GT INTNATL EQUITY FND, LP | AT COST | 4,637,473 | 5,448,108 |
| GT OFFSHORE FUND, LTD.-GTGH | AT COST | 2,478,771 | 4,913,822 |
| GT OFFSHORE FUND, LTD.-GTP | AT COST | 3,005,938 | 5,933,890 |
| GT PRIVATE EQUITY X-A, LP | AT COST | 463,671 | 532,309 |
| GT REAL ASSETS II, LP | AT COST | 366,625 | 632,521 |
| GT REAL ASSETS IV, LP | AT COST | 68,474 | 68,353 |
| GT REAL PROPERTY HOLDINGS IV | AT COST | 3,265 | 32,410 |
| GT SPECIAL OPPORTUNITIES III, LP | AT COST | 1,053,472 | 1,043,560 |
| GT US FUND, LP | AT COST | 1,301,013 | 2,483,485 |
| PALLADIAN PARTNERS IX, LLC | AT COST | 560,507 | 847,480 |
| PALLADIAN PARTNERS V, LLC | AT COST | 119,642 | 10,258 |
| PALLADIAN PARTNERS V-A, LLC | AT COST | 10,471 | 10,138 |
| PALLADIAN PARTNERS VII-A, LP | AT COST | 131,912 | 227,314 |
| PALLADIAN PARTNERS VIII, LP | AT COST | 289,983 | 531,572 |
| PIMCO ALL ASSET FUND | AT COST | 891,731 | 823,237 |
| SCHWAB TREASURY OBLIG SNOXX | AT COST | 129,851 | 129,851 |
| VANGUARD S&P 500 ETF | AT COST | 1,886,414 | 2,231,611 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| OFFICE SUPPLIES & SOFTWARE | 10,589 | 0 | 10,589 | |
| PROFESSIONAL DUES/PUBLICATIONS | 4,355 | 0 | 4,355 | |
| INSURANCE EXPENSE | 3,131 | 0 | 3,131 | |
| BANK CHARGES & WIRE FEES | 220 | 0 | 220 | |
| TRAINING & EDUCATION | 50 | 0 | 50 | |
| GT REAL ASSETS II, LP-NONDEDUCTIBLE EXP | 208 | 0 | 0 | |
| GT REAL ASSETS IV, LP-NONDEDUCTIBLE EXP | 7 | 0 | 0 | |
| PALLADIAN PARTNERS VII-A LP-NONDEDUCTIBLE EXP | 29 | 0 | 0 | |
| PALLADIAN PARTNRS IX LP-NONDEDUCTIBLE EXP | 140 | 0 | 0 | |
| PALLADIAN PARTNRS VIII LP-NONDEDUCTIBLE EXP | 174 | 0 | 0 | |
| GT US QP FUND, LP-NONDEDUCTIBLE EXP | 5 | 0 | 0 | |
| GT INTERNATIONAL EQUITY QP FUND, LP-NONDEDUCTIBLE EXP | 370 | 0 | 0 | |
| GT PRIVATE EQUITY X-A, LP-NONDEDUCTIBLE EXP | 91 | 0 | 0 | |
| GT SPECIAL OPPRTNTIES III, LP-NONDEDUCTIBLE EXP | 571 | 0 | 0 | |
| GT REAL PROPERTY HLDGS IV, LLC-NONDEDUCTIBLE EXP | 3 | 0 | 0 | |
| GT REAL PROP HLDGS IV, LLC | 349 | 349 | 0 | |
| PALLADIAN PARTNERS V, LLC | 662 | 662 | 0 | |
| PALLADIAN PARTNERS V-A, LLC | 633 | 633 | 0 | |
| 1607 CAPITAL BOND FUND, LP | 3,116 | 3,116 | 0 | |
| GT CREDIT OPPORTUNITY FUND, LP | 4,921 | 4,921 | 0 | |
| GT SPECIAL OPPRTNTIES III LP | 15,789 | 15,789 | 0 | |
| GT BIOTECH FUND, LP | 11,125 | 11,125 | 0 | |
| PALLADIAN PARTNERS VII-A, LP | 12,710 | 10,940 | 0 | |
| GT PRIVATE EQUITY X-A, LP | 26,920 | 26,920 | 0 | |
| PALLADIAN PARTNERS IX, LP | 20,206 | 20,206 | 0 | |
| PALLADIAN PARTNERS VIII, LP | 21,305 | 14,406 | 0 | |
| GT REAL ASSETS II, LP | 21,172 | 21,172 | 0 | |
| GT REAL ASSETS IV, LP | 4,574 | 3,163 | 0 | |
| GT INTL EQUITY FUND, LP | 70,353 | 70,353 | 0 | |
| GT US QP FUND, LP | 36,614 | 36,614 | 0 | |
| GT EMERGING MARKETS, LP | 50,682 | 50,682 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| GT EMERGING MARKETS, LP-OTHER INCOME | -726 | 1,111 | -726 |
| GT EMERGING MARKETS, LP-PORTFOLIO INCOME | 7,986 | 7,986 | 7,986 |
| PALLADIAN PARTNERS VIII, LP-ORDINARY INCOME | 12,190 | 0 | 12,190 |
| PALLADIAN PARTNERS VIII, LP-ORDINARY INCOME | 378 | 378 | 378 |
| PALLADIAN PARTNERS VIII, LP-ROYALTY, PORTFOLIO | 2,849 | 2,849 | 2,849 |
| PALLADIAN PARTNERS IX, LLC-PORTFOLIO INCOME | 92 | 92 | 92 |
| PALLADIAN PARTNERS IX, LP-ORDINARY LOSS | -499 | -499 | -499 |
| PALLADIAN PARTNERS IX, LP-ORDINARY INCOME | 2,001 | 0 | 2,001 |
| GT REAL ASSETS II, LP-ORDINARY INCOME | 6,350 | 6,350 | 6,350 |
| GT REAL ASSETS II, LP-ORDINARY INCOME | 2,577 | 0 | 2,577 |
| GT REAL ASSETS II, LP-PORTFOLIO & ROYALTY INC | 19,667 | 19,667 | 19,667 |
| GT REAL ASSETS IV, LP-ORDINARY INCOME | -1,483 | 0 | -1,483 |
| GT REAL ASSETS IV, LP-PORTFOLIO & ROYALTY INC | 1,146 | 1,146 | 1,146 |
| PALLADIAN PARTNERS VII-A, LP-PORTFOLIO INCOME | 56 | 56 | 56 |
| PALLADIAN PARTNERS VII-A, LP-ORDINARY INCOME | 8,036 | 8,036 | 8,036 |
| PALLADIAN PARTNERS VII-A, LP-ORDINARY INCOME | 1,687 | 0 | 1,687 |
| GT CREDIT OPPRTNTY FUND, LP-PORFOLIO INCOME | 7 | 7 | 7 |
| GT CREDIT OPPRTNTY FUND, LP-ORDINARY INCOME | 463 | 463 | 463 |
| GT CREDIT OPPRTNTY FUND, LP-OTHER INCOME | -596 | 0 | -596 |
| GT BIOTECH FUND, LP-OTHER INCOME | 879 | 879 | 879 |
| GT BIOTECH FUND, LP-OTHER LOSS | -98 | 0 | -98 |
| GT BIOTECH FUND, LP-PORTFOLIO INCOME | 1,089 | 1,089 | 1,089 |
| GT PRIVATE EQUITY X-A, LP-PORTFOLIO INCOME | 31 | 31 | 31 |
| GT PRIVATE EQUITY X-A, LP-ORDINARY LOSS | -5,369 | 0 | -5,369 |
| GT PRIVATE EQUITY X-A, LP-ORDINARY INCOME | 707 | 707 | 707 |
| GT US QP FUND, LP-OTHER INCOME | 974 | 974 | 974 |
| GT US QP FUND, LP-PORTFOLIO INCOME | 500 | 500 | 500 |
| GT US QP FUND, LP-OTHER LOSS | -803 | 0 | -803 |
| GT SPECIAL OPPRTNTIES III, LP-PORTFOLIO INCOME | 3,551 | 3,551 | 3,551 |
| GT INTRNATL EQUITY QP FUND, PORTFOLIO INCOME | -5,412 | -5,412 | -5,412 |
| GTRP HOLDINGS IV, LLC-ORDINARY LOSS | -123 | 0 | -123 |
| Borrower's Name | Relationship to Insider | Original Amount of Loan | Balance Due | Date of Note | Maturity Date | Repayment Terms | Interest Rate | Security Provided by Borrower | Purpose of Loan | Description of Lender Consideration | Consideration FMV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPITAL FOR CHANGE INC | NONE | 10,000 | 0 | 2020-01 | 2025-01 | 300.0000000000 % | NONE | GENERAL OPERATING | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PAYROLL TAXES | 13,113 | 366 | 12,747 | |
| 990-PF TAX PAYMENTS | 0 | 0 | 0 | |
| 990-T TAX PAYMENTS, NET OF REFUND | 18,000 | 0 | 0 | |
| TN TAXES, NET OF REFUND | 3,445 | 3,445 | 0 | |
| ALLOCATED TO 990-T | 0 | -3,445 | 0 | |
| PALLADIAN PARTNERS VII-A, LP-STATE TAXES | 45 | 45 | 0 | |
| PALLADIAN PARTNERS IX, LP-STATE TAXES | 385 | 385 | 0 | |
| PALLADIAN PARTNERS VIII, LP-STATE TAXES | 651 | 651 | 0 | |
| GT REAL ASSETS II, LP-STATE TAXES | 153 | 153 | 0 | |
| GT US QP FUND, LP-FOREIGN TAXES | 298 | 298 | 0 | |
| GT INTL EQUITY FUND, LP-FOREIGN TAXES | 18,487 | 18,487 | 0 | |
| GT EMERGING MARKETS, LP-FOREIGN TAXES | 2,896 | 2,896 | 0 | |
| GT REAL ASSETS II, LP-FOREIGN TAXES | 178 | 178 | 0 | |
| PALLADIAN PARTNERS V, LLC-FOREIGN TAXES | 22 | 22 | 0 | |
| PALLADIAN PARTNERS V-A, LLC-FOREIGN TAXES | 22 | 22 | 0 | |
| PALLADIAN PARTNERS VII-A, LP-FOREIGN TAXES | 89 | 89 | 0 | |
| PALLADIAN PARTNERS VIII, LP-FOREIGN TAXES | 86 | 86 | 0 | |
| PALLADIAN PARTNERS IX, LLC-FOREIGN TAXES | 7 | 7 | 0 | |
| GT SPECIAL OPPORTUNITIES III, LP-FOREIGN TAXES | 3,052 | 3,052 | 0 | |
| GT BIOTECH FUND, LP-FOREIGN TAXES | 14 | 14 | 0 |